Two noninferiority, randomized, controlled trials were conducted in parallel comparing the safety and efficacy of platelets treated with Intercept or Mirasol pathogen-reduction technologies versus standard platelets.

Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies

Montemezzi, Rachele
;
2017

Abstract

Two noninferiority, randomized, controlled trials were conducted in parallel comparing the safety and efficacy of platelets treated with Intercept or Mirasol pathogen-reduction technologies versus standard platelets.
Adolescent; Adult; Aged; Aged, 80 and over; Antisepsis; Blood Preservation; Disease Transmission, Infectious; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Count; Platelet Transfusion; Young Adult
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/979156
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact